<DOC>
	<DOCNO>NCT00509275</DOCNO>
	<brief_summary>In phase Ib , multi-centre , randomize , double-blind , placebo-controlled parallel group study , 120 subject moccasin type tinea pedis ( MTTP ) enrol approximately 11 centre USA , Canada Australia . The primary objective study assess patient response three W0027 regimens subject MTTP . Secondary objective include assessment safety , tolerability skin nail pharmacokinetics three Albaconazole regimen .</brief_summary>
	<brief_title>A Study Evaluate Efficacy Safety Three W0027 Regimens Treatment Moccasin Type Tinea Pedis ( MTTP )</brief_title>
	<detailed_description />
	<mesh_term>Tinea</mesh_term>
	<mesh_term>Tinea Pedis</mesh_term>
	<criteria>Subjects age 1865 year , diagnose moccasin type tinea pedis ( positive dermatophyte culture , positive potassium hydroxide/calcofluor white preparation , Total Signs Symptoms Score least 4 ) . Females childbearing potential must use contraceptive method . Subjects receive CYP3A substrates potential QT prolongation ; use systemic antifungal drug within 30 day first dose ; topical antifungal within 2 week first dose . Also exclude clinically significant medical condition .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2010</verification_date>
</DOC>